China Pharma Holdings (CPHI) Short-term Investments (2013 - 2019)

China Pharma Holdings (CPHI) posted Short-term Investments of $109908.0 for Q4 2019, down 99.75% on a QoQ basis from $43.1 million in Q2 2015.

China Pharma Holdings (CPHI) Short-term Investments (2013 - 2019) Analysis & Trends

China Pharma Holdings' Short-term Investments history runs 4 years deep, the most recent figure standing at $109908.0 for Q4 2019.

Quarterly Short-term Investments changed N/A year-over-year to $109908.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $109908.0 (changed N/A YoY) and the FY2019 annual result came in at $109908.0, changed N/A from the prior year.
Short-term Investments was $109908.0 for Q4 2019 at China Pharma Holdings, down from $43.1 million in the prior quarter.
Across five years, Short-term Investments topped out at $43.1 million in Q2 2015 and bottomed at $109908.0 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	China Pharma Holdings	629,344.02	460,870.02	285,487.00

Download Data